Tag: genomics
-
System Slashes Time to Detect Bacteria in Blood
A biomedical engineering lab developed a compact system that detects harmful bacteria in blood samples in less than four hours, a process that now takes days.
-
DNA Tags Speed Nanoparticle Gene Therapy Discovery
Biomedical engineers developed a technique with unique DNA identifiers that makes possible faster screening of gene therapies delivered with nanoscale particles.
-
Alliance to Study Brain Tumor Precision Diagnostics
A group of medical centers and companies, mainly in Philadelphia, is beginning a study of genomic profiling to diagnose brain tumors in adults and children.
-
Biopharm, Hospital to Partner on Cell Energy Diseases
A biopharmaceutical company in Sweden and children’s hospital in the U.S. are collaborating on research into deficiencies in cells’ energy components responsible for a number of genetic disorders.
-
Safer Engineered-Cell Cancer Immunotherapy Designed
A biotechnology company designed a new type of engineered T-cell from the immune system that more precisely targets tumors and stays away from healthy cells.
-
Knowledge Bank Tapped for Precision Cancer Treatments
An international research team devised techniques for analyzing accumulated clinical trial data to help determine precise treatment strategies for people with cancer.
-
Electronic Gene Editing Corrects Inherited Blood Disorder
A team at National Institutes of Health used an electronic-aided process to carry out a gene editing technique that in lab mice repaired a genetic defect causing a rare blood disease.
-
RNA-Nanoparticle Spray Protects Against Plant Viruses
Plant scientists combined synthetic genetic material with clay nanoparticles, which when sprayed on plants provides enduring protection against viruses.
-
Scripps, Pfizer Collaborate on DNA-Coded Drug Discovery
Drug maker Pfizer Inc. is gaining access to advances in a synthetic chemistry technology developed by Scripps Research Institute that tags compounds with DNA identifiers.
-
Illumina Partnering with IBM, Phillips on Genomics Tools
Genomics technology company Illumina Inc. is collaborating with technology enterprises IBM and Royal Phillips to expand its sequencing services in precision medicine for cancer.